Literature DB >> 15629377

Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography.

Peter W Groeneveld1, Paul A Heidenreich, Alan M Garber.   

Abstract

OBJECTIVES: The study was designed to determine whether racial disparity in utilization of the implantable cardioverter-defibrillator (ICD) has improved over time, and whether small-area geographic variation in ICD utilization contributed to national levels of racial disparity.
BACKGROUND: Although racial disparities in cardiac procedures have been well-documented, it is unknown whether there has been improvement over time. Low ICD utilization rates in predominantly black geographic areas may have exacerbated national levels of disparity.
METHODS: Discharge abstracts from elderly black and white Medicare beneficiaries hospitalized with ventricular arrhythmias from 1990 to 2000 were analyzed to determine if ICD implantation occurred within 90 days of initial hospitalization. Multivariate logistic regression models were constructed to assess the relationship between ICD implantation, year of admission, and the percentage of black inhabitants in each patient's county of hospitalization while controlling for clinical, hospital, and demographic characteristics.
RESULTS: There was improvement in ICD implantation racial disparity: In the period 1990 to 1992, black patients had an odds ratio of 0.52 (95% confidence interval [CI] 0.42 to 0.64) for receiving an ICD compared with whites. However, by 1999 to 2000, the odds ratio for blacks had risen to 0.69 (95% CI 0.61 to 0.78) (test-for-trend p=0.01). Approximately 20% of this trend could be explained by reduction in geographic variation in ICD use between areas with larger black and predominantly white populations.
CONCLUSIONS: Rates of ICD implants became more equal among whites and blacks during the 1990s, although persistent disparity remained at the decade's end. Geographic equalization in cardiovascular procedure rates may be an essential mechanism in rectifying disparities in health care.

Entities:  

Mesh:

Year:  2005        PMID: 15629377     DOI: 10.1016/j.jacc.2004.07.061

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Racial variations in the choice of on-pump versus off-pump coronary artery bypass grafting.

Authors:  Dana Mukamel; Laurent Glance; David Weimer; Thomas Pearson; Todd Massey; Jeffery Gold; Sheldon Greenfield; James Jackson; Alvin Mushlin
Journal:  J Health Serv Res Policy       Date:  2007-01

2.  Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged.

Authors:  Peter W Groeneveld; Andrew J Epstein; Feifei Yang; Lin Yang; Daniel Polsky
Journal:  Health Aff (Millwood)       Date:  2011-02       Impact factor: 6.301

3.  Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.

Authors:  Daniel B Kramer; Sharon-Lise T Normand; Rita Volya; Laura A Hatfield
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-12

4.  Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region.

Authors:  Allen Hoang; Changyu Shen; James Zheng; Stanley Taylor; William J Groh; Marc Rosenman; Alfred E Buxton; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2014-02-22       Impact factor: 6.343

5.  Racial differences in attitudes toward innovative medical technology.

Authors:  Peter W Groeneveld; Seema S Sonnad; Anee K Lee; David A Asch; Judy E Shea
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

6.  Do physicians' attitudes toward implantable cardioverter defibrillator therapy vary by patient age, gender, or race?

Authors:  Sana M Al-Khatib; Gillian D Sanders; Sean M O'Brien; Daniel Matlock; Louise O Zimmer; Frederick A Masoudi; Eric Peterson
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

7.  National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy.

Authors:  Madhab Lamichhane; Joseph C Gardiner; Nicole R Bianco; Steven J Szymkiewicz; Ranjan K Thakur
Journal:  J Interv Card Electrophysiol       Date:  2016-10-17       Impact factor: 1.900

8.  Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Authors:  Judith E Mitchell; Anne S Hellkamp; Daniel B Mark; Jill Anderson; Jeanne E Poole; Kerry L Lee; Gust H Bardy
Journal:  Am Heart J       Date:  2007-12-19       Impact factor: 4.749

9.  Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996-2001.

Authors:  Ava Stanley; Derek DeLia; Joel C Cantor
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

10.  Racial and gender trends in the use of implantable cardioverter-defibrillators among Medicare beneficiaries between 1997 and 2003.

Authors:  Paul S Chan; John D Birkmeyer; Harlan M Krumholz; John A Spertus; Brahmajee K Nallamothu
Journal:  Congest Heart Fail       Date:  2009 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.